📅Offer Date: 21 Nov 2025 – 25 Nov 2025
Data sourced from BSE & NSE · Last updated
Sudeep Pharma Limited IPO was subscribed 93.71x in total when bidding closed on 25 Nov 2025, with 213.08x in the QIB category, 116.72x in NII, 15.65x in retail. The issue ran from 21 Nov 2025 to 25 Nov 2025 at a price band of ₹563.00–₹593.00 per share.
Times subscribed by category against the 1× line.
Based on retail subscription (15.65x). Final allotment decided by registrar's computerised lottery.
| Category | Offer | Applied | Times |
|---|---|---|---|
| QIBs | 30,18,553 | 64,31,93,273 | 213.08x |
| NIIs | 22,63,912 | 26,42,43,809 | 116.72x |
| SNIIs (<10L) | 7,54,637 | 6,06,19,990 | 80.33x |
| BNIIs (>10L) | 15,09,275 | 20,36,16,290 | 134.91x |
| Retail | 52,82,462 | 8,26,70,530 | 15.65x |
| Total | 1,05,64,927 | 99,00,39,309 | 93.71x |
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIBs | 179.00 | 38141.36 | 213.08x |
| NIIs | 134.25 | 15669.66 | 116.72x |
| Retail | 313.25 | 4902.36 | 15.65x |
| Total | 626.50 | 58713.38 | 93.71x |
Values derived from share count × issue price (₹593.00)
Because Sudeep Pharma Limited closed oversubscribed, allotment follows the applicable category and exchange rules. A high subscription figure reflects strong demand but does not guarantee a premium listing, and a low figure does not guarantee a discount. This page is for information only and is not investment advice.
BSE, NSE listed · Bidding data sourced from BSE & NSE under SEBI ICDR regulations.